Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference
Verastem Oncology (Nasdaq: VSTM) announced its management team's upcoming participation in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. The presentation is scheduled for Tuesday, December 3rd at 11:15 am EST.
The event will be accessible through a live webcast under the 'Events & Presentations' section of Verastem's website. A replay will remain available on the website for approximately 90 days after the presentation.
Verastem Oncology (Nasdaq: VSTM) ha annunciato la partecipazione del suo team di gestione a una chiacchierata informale durante la 7ª Conferenza Annuale HealthCONx di Evercore ISI. La presentazione è prevista per martedì 3 dicembre alle 11:15 ora EST.
L'evento sarà accessibile tramite un webcast in diretta nella sezione 'Eventi e Presentazioni' del sito web di Verastem. Una registrazione sarà disponibile sul sito per circa 90 giorni dopo la presentazione.
Verastem Oncology (Nasdaq: VSTM) anunció la próxima participación de su equipo de gestión en una charla informal en la 7ª Conferencia Anual HealthCONx de Evercore ISI. La presentación está programada para el martes 3 de diciembre a las 11:15 am EST.
El evento será accesible a través de un webcast en vivo en la sección 'Eventos y Presentaciones' del sitio web de Verastem. Una grabación estará disponible en el sitio durante aproximadamente 90 días después de la presentación.
Verastem Oncology (Nasdaq: VSTM)은 관리 팀이 7회 연례 Evercore ISI HealthCONx 컨퍼런스에서 진행하는 화상 대화에 참석할 것이라고 발표했습니다. 프레젠테이션은 12월 3일 화요일 오전 11시 15분 EST로 예정되어 있습니다.
이 이벤트는 Verastem 웹사이트의 '이벤트 및 프레젠테이션' 섹션에서 실시간 웹캐스트를 통해 접근할 수 있습니다. 프레젠테이션 이후 약 90일 동안 웹사이트에서 재생할 수 있습니다.
Verastem Oncology (Nasdaq: VSTM) a annoncé la prochaine participation de son équipe de direction à une discussion informelle lors de la 7e Conférence Annuelle HealthCONx d'Evercore ISI. La présentation est prévue pour le mardi 3 décembre à 11h15 EST.
L'événement sera accessible via un webinaire en direct dans la section 'Événements et Présentations' du site Web de Verastem. Un enregistrement restera disponible sur le site pendant environ 90 jours après la présentation.
Verastem Oncology (Nasdaq: VSTM) gab bekannt, dass sein Management-Team an einem Fireside-Chat auf der 7. jährlichen HealthCONx-Konferenz von Evercore ISI teilnehmen wird. Die Präsentation ist für Dienstag, den 3. Dezember um 11:15 Uhr EST angesetzt.
Die Veranstaltung wird über einen Live-Webcast im Bereich 'Veranstaltungen & Präsentationen' der Verastem-Website zugänglich sein. Eine Aufzeichnung wird für etwa 90 Tage nach der Präsentation auf der Website verfügbar sein.
- None.
- None.
A live webcast of the fireside chat can be accessed under “Events & Presentations” in the Investors & Media section of the company’s website at www.verastem.com. A replay of the webcast will be archived on the website for approximately 90 days following the presentation.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126619132/en/
For Investor and Media Inquiries:
Julissa Viana
Vice President, Corporate Communications and Investor Relations
investors@verastem.com or
media@verastem.com
Source: Verastem Oncology
FAQ
When is Verastem Oncology (VSTM) presenting at the Evercore ISI HealthCONx Conference?
How can I watch Verastem Oncology's (VSTM) presentation at the HealthCONx Conference?
How long will Verastem Oncology's (VSTM) HealthCONx Conference presentation replay be available?
What type of presentation is Verastem Oncology (VSTM) giving at the HealthCONx Conference?
